- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06313320
Intraoperative Electroencephalographic Biomarkers of Postoperative Pain
March 12, 2024 updated by: University of Chile
Determination of the Association of Intraoperative Nociception Electroencephalographic Biomarkers and Postoperative Pain
The goal of this study is to explore whether specific intraoperative EEG signals (brain waves or neuronal electrical activity) are associated with the severity of acute postoperative pain.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
This is a prospective minimal-risk observational study to collect and analyze EEG data during intraepidermal electrical stimulation in patients receiving general anesthesia (GA) for abdominal surgery.
To collect nociception-related EEG signal during GA the investigators designed a standardized Intraepidermal Electrical Stimulation (IES) Protocol.
The intensity of the electrical stimulus will be calibrated to each participant perception pre-surgery, with 3 different intensities: sensitivity threshold, mild-pain threshold, and moderate-pain threshold.
The IES will be administered several times throughout the surgical procedure: a) At baseline, prior to induction of GA, b) Three minutes after loss of consciousness, c) Five minutes after fentanyl administration and orotracheal intubation, d) Five minutes after first incision and every 20 minutes until the end of the surgery, and f) After surgery ends and before extubation.
To standardize the anesthesia management as much as possible, all patients will be attended by a reduced number of anesthesiologists.
The hypnosis will be achieved with propofol, while analgesia will be mainly achieved with either fentanyl or remifentanil.
EEG will be recorded with a 32-channel high standard equipment.
Once the patient arrives to the Post-Anesthesia Care Unit (PACU), the investigators will record the pain reported by the patient using the Numeric Pain Rating Scale every 15 minutes during the first hour, and every 30 minutes until patient is discharged from the PACU.
Also, the investigators will both, record opioid administration through the surgery and estimate their effect-site concentration with pharmacokinetic/pharmacodynamic models.
Besides, the investigators will measure opioid plasmatic concentrations.
Study Type
Observational
Enrollment (Estimated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rodrigo Gutierrez, MD, PhD
- Phone Number: +56995993665
- Email: rodrgutierrez@uchile.cl
Study Locations
-
-
-
Santiago, Chile
- Centro de Investigacion Clinica Avanzada
-
-
RM
-
Santiago, RM, Chile, 7563215
- Hospital Clinico de la Universidad de Chile
-
Contact:
- Rodrigo Gutierrez, MD, PhD
- Phone Number: +56995993665
- Email: rodrgutierrez@uchile.cl
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Adult patients schedule for elective abdominal surgery under general anesthesia.
Description
Inclusion Criteria:
- American Society of Anesthesiologist Performance Status I or II
- Scheduled for elective laparoscopic abdominal surgery under General Anesthesia
Exclusion Criteria:
- Body Mass Index > 35 kg/m2
- Past history or suspected difficult airway
- Craniofacial malformations
- Use of regional anesthesia technique during or after the surgery
- Severe arrhythmia or use of a pacemaker device
- Severe neuropsychiatric illness (Mayor depression, bipolar disorder, schizophrenia)
- Regular use of psychoactive drugs
- Any injury in the right hand
- Past history of peripheral neuropathy
- Diabetes Mellitus
- Known lesion in the spinothalamic tract.
- Analgesics used in the past 72 hours
- Known allergy to propofol
- Previous diagnosis of a condition associated with chronic pain (such as fibromyalgia, rheumatoid arthritis, osteoarthritis, migraine)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximum Pain in PACU
Time Frame: From PACU Admission to PACU Discharged, an average of 2 hours
|
Pain is evaluated several times during PACU stay using the Numeric Rating Scale (from 0 to 10).
Discrete Numerical Variable
|
From PACU Admission to PACU Discharged, an average of 2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Opioid Consumption in PACU
Time Frame: From PACU Admission to PACU Discharged, an average of 72 hours
|
Total opioid administered during PACU stay in Morphine Milligram Equivalent (MME).
Continuous Numerical Variable.
|
From PACU Admission to PACU Discharged, an average of 72 hours
|
Maximum Pain at 24h
Time Frame: From PACU discharged to 24 hours after PACU discharged
|
Pain is evaluated several times during hospital stay using the Numeric Rating Scale (from 0 to 10).
This outcome corresponds to the maximum pain reported by the patient during the time frame.
Discrete Numerical Variable.
|
From PACU discharged to 24 hours after PACU discharged
|
Presence of surgical related pain at day 7
Time Frame: 7 days after the surgery (+- 1 day)
|
Pain of any intensity (Numeric Rating Scale >1) reported by the patient 7 days after the surgery
|
7 days after the surgery (+- 1 day)
|
Presence of surgical related pain at day 30
Time Frame: 30 days after surgery (+- 3 day)
|
Pain of any intensity (Numeric Rating Scale >1) reported by the patient 30 days after the surgery
|
30 days after surgery (+- 3 day)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rodrigo Gutierrez, MD, PhD, University of Chile
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014 Jan;30(1):149-60. doi: 10.1185/03007995.2013.860019. Epub 2013 Nov 15.
- Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet. 2019 Apr 13;393(10180):1537-1546. doi: 10.1016/S0140-6736(19)30352-6.
- Garcia PS, Kreuzer M, Hight D, Sleigh JW. Effects of noxious stimulation on the electroencephalogram during general anaesthesia: a narrative review and approach to analgesic titration. Br J Anaesth. 2021 Feb;126(2):445-457. doi: 10.1016/j.bja.2020.10.036.
- Baharloo R, Principe JC, Fillingim RB, Wallace MR, Zou B, Crispen PL, Parvataneni HK, Prieto HA, Machuca TN, Mi X, Hughes SJ, Murad GJA, Rashidi P, Tighe PJ. Slow Dynamics of Acute Postoperative Pain Intensity Time Series Determined via Wavelet Analysis Are Associated With the Risk of Severe Postoperative Day 30 Pain. Anesth Analg. 2021 May 1;132(5):1465-1474. doi: 10.1213/ANE.0000000000005385.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 1, 2024
Primary Completion (Estimated)
March 1, 2026
Study Completion (Estimated)
June 1, 2026
Study Registration Dates
First Submitted
March 6, 2024
First Submitted That Met QC Criteria
March 12, 2024
First Posted (Actual)
March 15, 2024
Study Record Updates
Last Update Posted (Actual)
March 15, 2024
Last Update Submitted That Met QC Criteria
March 12, 2024
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OAIC1344-23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nociceptive Pain
-
University Malaysia SarawakPersatuan Diabetes MalaysiaCompletedNeuropathic Pain, Nociceptive PainMalaysia
-
Aretaieion University HospitalRecruitingPain, Postoperative | Analgesia | Pain, Acute | Magnesium | Pain, NociceptiveGreece
-
Icahn School of Medicine at Mount SinaiEndo PharmaceuticalsUnknownNeuropathic Pain | Non-cancer Pain | Chronic Nociceptive PainUnited States
-
University Hospital, Basel, SwitzerlandCompletedHyperalgesia | Allodynia | Opioid-induced Hyperalgesia | Acute Nociceptive PainSwitzerland
-
Evangelismos HospitalAretaieion University HospitalRecruitingPain, Postoperative | Analgesia | Pain, Acute | Ketamine | Pain, Chronic | Lidocaine | Analgesics | Cervical Spine Surgery | Pain, NociceptiveGreece
-
Aretaieion University HospitalRecruitingPain, Postoperative | Analgesia | Pain, Acute | Ketamine | Dexmedetomidine | Pain, Chronic | Lidocaine | Analgesics | Lumbar Spine Surgery | Pain, NociceptiveGreece
-
Université Catholique de LouvainNot yet recruiting
-
Université Catholique de LouvainCompleted
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Tribhuvan University Teaching Hospital, Institute...Not yet recruiting